TNF Pharmaceuticals
Baltimore
About TNF Pharmaceuticals
TNF Pharmaceuticals is researching groundbreaking treatments to address serious and debilitating autoimmune and inflammatory illnesses.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $29.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Sep 2025)
- Ticker: nasdaq:TNFA
- Website: tnfpharma.com
- Phone: +1 813) 864-2566
Industries & Categories
Biotechnology, Clinical Trials, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/tnf-pharmaceuticals-169282 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.